Target intelligence / Profile preview

Striatin, calmodulin-binding protein pseudogene

Molecular classification
Pseudogene, Non-coding element
01

Overview

This entry represents a pseudogene annotated as related to striatin, a neuronal calmodulin-binding protein. Pseudogenes are genomic elements resembling functional genes but are rendered non-coding and inactive, typically due to frame shifts, truncations, or other inactivating mutations. While the protein-coding STRN gene (striatin) encodes a calmodulin-binding scaffolding protein involved in multiple signaling pathways, the striatin, calmodulin binding protein pseudogene is considered non-coding and lacks evidence for protein translation or direct therapeutic relevance. Pseudogenes were traditionally viewed as "junk DNA," but recent studies suggest some may have RNA-level regulatory effects; there is no evidence that this particular pseudogene has such a role. It is not considered a therapeutic target and should generally be excluded from druggable genome or actionable gene sets. The entity ENSG00000275490 is a pseudogene related to striatin and does not encode a functional receptor, enzyme, transporter, or other actionable protein target. It is not used in therapy, biomarker panels, and has no associated drugs or therapeutic mechanism. There is nothing to suggest that its sequence or annotation is incorrect, but it is not suitable for use as a canonical drug target for therapeutic or biomarker purposes.

Other names
striatin pseudogenecalmodulin-binding protein pseudogeneSTRN pseudogene
02

Biological functions

No known protein-coding or canonical biological functionPotential post-transcriptional regulatory roles (as competing endogenous RNA, antisense RNA, or siRNA), but this is not confirmed for this specific pseudogene and is speculative
03

Disease associations

None established for this specific pseudogeneGeneric pseudogene-related roles in cancer and gene regulation are speculative and not described for this entry specifically

Beyond the preview

Go deeper on Striatin, calmodulin-binding protein pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Striatin, calmodulin-binding protein pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call